검색어 : 통합검색[Maynard Lucian]
-
1
-
Reviews : Cooking for Diabetics, by Kitty Maynard, RN; Lucian Maynard, RN; and Theodore Duncan, MD. (1989). Rutledge Hill Press, 513 Third Avenue South, Nashville, TN 37210. 217 pages. Price: $17.95
-
McAfee, Frances;
;
(The Diabetes educator,
v.15,
1989,
pp.425-427)
-
2
-
Abstract B01: BLU-667: A highly selective RET inhibitor to target RET-driven NSCLC
-
Rahal, Rami;
Maynard, Michelle;
Hu, Wei;
Brubaker, Jason;
Cao, Qiangfang;
Kim, Joseph L.;
Sheets, Michael P.;
Wilson, Douglas P.;
Wilson, Kevin J.;
DiPietro, Lucian;
LaBranche, Timothy;
Wolf, Beni;
Guzi, Timothy;
Lengauer, Christoph;
Evans, Erica K.;
;
(Clinical Cancer research : an official journal of the American Association for Cancer Research,
v.24,
2018,
pp.B01-B01)
-
3
-
Abstract 2641: The development of potent, selective RET inhibitors that target both wild-type RET and prospectively identified resistance mutations to multi-kinase inhibitors
-
Rahal, Rami;
Evans, Erica K.;
Hu, Wei;
Maynard, Michelle;
Fleming, Paul;
DiPietro, Lucian;
Kim, Joseph L.;
Sheets, Michael P.;
Wilson, Doug P.;
Wilson, Kevin J.;
Stransky, Nicolas;
Brubaker, Jason D.;
Guzi, Timothy;
Kohl, Nancy E.;
Lengauer, Christoph;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
Blueprint Medicines, Cambridge, MA.;
(Cancer research : the official organ of the American Association for Cancer Research, Inc,
v.76,
2016,
pp.2641-2641)
-
4
-
Abstract B151: BLU-667 is a potent and highly selective RET inhibitor being developed for <i>RET</i>-driven cancers
-
Rahal, Rami;
Maynard, Michelle;
Hu, Wei;
Brubaker, Jason;
Cao, Qiongfang;
Kim, Joseph L.;
Sheets, Michael P.;
Wilson, Douglas P.;
Wilson, Kevin J.;
DiPietro, Lucian;
Fleming, Paul;
LaBranche, Timothy P.;
Wolf, Beni;
Guzi, Timothy;
Lengauer, Christoph;
Evans, Erica K.;
;
(Molecular cancer therapeutics,
v.17,
2018,
pp.B151-B151)
-
5
-
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven Cancers
-
Subbiah, Vivek;
Gainor, Justin F.;
Rahal, Rami;
Brubaker, Jason D.;
Kim, Joseph L.;
Maynard, Michelle;
Hu, Wei;
Cao, Qiongfang;
Sheets, Michael P.;
Wilson, Douglas;
Wilson, Kevin J.;
DiPietro, Lucian;
Fleming, Paul;
Palmer, Michael;
Hu, Mimi I.;
Wirth, Lori;
Brose, Marcia S.;
Ou, Sai-Hong Ignatius;
Taylor, Matthew;
Garralda, Elena;
Miller, Stephen;
Wolf, Beni;
Lengauer, Christoph;
Guzi, Timothy;
Evans, Erica K.;
Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.;
Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Blueprint Medicines Corporation, Cambridge, Massachusetts.;
Department of Endocrine Neoplasia and;
(Cancer discovery,
v.8,
2018,
pp.836-849)
-
6
-
Chronic Hepatitis B Treatment Initiation and Modification Patterns in Five European Countries: A 2-Year Longitudinal, Non-Interventional Study
-
Marcellin, Patrick;
Arama, Victoria;
Leblebicioglu, Hakan;
Zarski, Jean Pierre;
Zeuzem, Stefan;
Mauss, Stefan;
Sieklucki, Jerzy;
Acalovschi, Monica;
Usluer, Gaye;
Klauck, Isabelle;
Morais, Edith;
Bjork, Stefan;
Lescrauwaet, Benedicte;
Kamar, Driss;
Simon, Krzysztof;
Botta-Fridlund, Danielle;
Pol, Stanislas;
Maynard, Marianne;
Habersetzer, Franç
ois;
Causse, Xavier;
Alric, Laurent;
Simo Noumbissie, Pauline;
Gerken, Guido;
Goeser, Tobias;
Niederau, Claus;
Wiese, Manfred;
Busch, Heiner;
Schneider, Lothar;
Schubert, Jens;
Brenner, Meike;
Scheffrahn, Inka;
Vermehren, Johannes;
Bludzin, Wieslawa;
Dziambor, Andrzej;
Goryszewski, Dariusz;
Postawa-Klosinska, Barbara;
Pleś
niak, Robert;
Tanasescu, Coman;
Raducan, Lucian;
Sporea, Ioan;
Jinga, Mariana;
Voiculescu, Mihai;
Chira, Olimpia;
Stefan Arama, Sorin;
Andreea Radulescu, Mihaela;
Nicolau, Adriana;
Nitescu, Doina;
Nanu, Andrei;
Dan, Isabel;
Nicolita, Diana;
Ionescu, Camelia;
Ecobici;
Service Hepato-Gastroenterology, Hopital Beaujon, Paris, France;
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
Department of Infectious Diseases and Clinical Microbiology, Medical School, Ondokuz Mayis University, Samsun, Turkey;
Clinique Universitaire d'Hé
pato-Gastroenté
rologie, CHU de Grenoble, Grenoble, France;
Department of Medicine, JW Goethe University Hospital, Frankfurt, Germany;
Center for HIV and Hepatogastroenterology, Duesseldorf, Germany;
Department of Infectious Diseases, Medical Center, Łań
cut, Poland;
University of Medicine and Pharmacy, Cluj-Napoca, Romania;
Department of Infectious Diseases and Clinical Microbiology, Medical School, Osmangazi University, Eskisehir, Turkey;
Bristol-Myers Squibb, Paris, France;
Bristol-Myers Squibb, Paris, France;
Service Hepato-Gastroenterology, Hopital Beaujon, Paris, France;
Service Hepato-Gastroenterology, Hopital Beaujon, Paris, France;
Service Hepato-Gastroenterology, Hopi;
(Antiviral therapy,
v.19,
2014,
pp.235-243)
-
7
-
Chronic Hepatitis B Monitoring and Treatment Patterns in Five European Countries with Different Access and Reimbursement Policies
-
Arama, Victoria;
Leblebicioglu, Hakan;
Simon, Krzysztof;
Zarski, Jean Pierre;
Niederau, Claus;
Habersetzer, Franç
ois;
Vermehren, Johannes;
Bludzin, Wieslawa;
Jinga, Mariana;
Ulusoy, Sercan;
Klauck, Isabelle;
Morais, Edith;
Bjork, Stefan;
Lescrauwaet, Benedicte;
Kamar, Driss;
Zeuzem, Stefan;
Marcellin, Patrick;
Botta-Fridlund, Danielle;
Pol, Stanislas;
Maynard, Marianne;
Habersetzer, Franç
ois;
Causse, Xavier;
Alric, Laurent;
Simo Noumbissie, Pauline;
Mauss, Stefan;
Gerken, Guido;
Goeser, Tobias;
Wiese, Manfred;
Busch, Heiner;
Schneider, Lothar;
Schubert, Jens;
Brenner, Meike;
Scheffrahn, Inka;
Dziambor, Andrzej;
Goryszewski, Dariusz;
Postawa-Klosinska, Barbara;
Sieklucki, Jerzy;
Pleś
niak, Robert;
Acalovschi, Monica;
Tanasescu, Coman;
Raducan, Lucian;
Sporea, Ioan;
Voiculescu, Mihai;
Chira, Olimpia;
Stefan Arama, Sorin;
Andreea Radulescu, Mihaela;
Nicolau, Adriana;
Nitescu, Doina;
Munteanu, Daniela Ioana;
Nanu, Andrei;
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
Department of Infectious Diseases and Clinical Microbiology, Medical School, Ondokuz Mayis University, Samsun, Turkey;
Wroclaw University of Medicine, Wroclaw, Poland;
Clinique Universitaire d'Hé
pato-Gastroenté
rologie, CHU de Grenoble, Grenoble, France;
Katholische Kliniken Oberhausen, St Josef Hospital, Klinik fü
r Innere Medizin, Oberhausen, Germany;
Pô
le Hé
pato-digestif, Unité
Inserm U.1110, Université
de Strasbourg, Laboratoire d'Excellence HepSys, Strasbourg, France;
Medizinische Klinik 1, Klinikum der JW Goethe-Universitä
t, Frankfurt am Main, Germany;
Szpital Wojew. w Opolu, Opole, Poland;
Dr Carol Davila Central University Emergency Military Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
Bristol-Myers Squibb, Paris, France;
Bristol-Myers Squibb, Par;
(Antiviral therapy,
v.19,
2014,
pp.245-257)
1